A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks

Psychopharmacol Bull. 2020 Oct 15;50(4 Suppl 1):121-141.

Abstract

Purpose of review: This evidence-based systematic review will focus on the use of dexmedetomidine and its role as adjuvant anesthetics in regional blocks to help better guide physicians in their practice. This review will cover background and mechanism of dexmedetomidine as well as the use in various regional blocks.

Recent findings: Local anesthetics are preferred for nerve blocks over opioids; however, both due come with its own side effects. Local anesthetics may be toxic as they disrupt cell membrane and proteins, but by using adjuvants such as dexmedetomidine, that can prolong sensory and motor blocks can reduce total amount of local anesthetics needed. Dexmedetomidine is an alpha-2-adrenergic agonist used as additive for regional nerve block. It has a relatively low side effect profile and have been researched in various regional blocks (intrathecal, paravertebral, axillary, infraclavicular brachial plexus, interscalene). Dexmedetomidine shows promising results as adjuvant anesthetics in most regional blocks.

Summary: Many studies have been done and many show promising results for the use of dexmedetomidine in regional blocks. It may significantly increase in duration of sensory and motor blocks that correlates with lower pain scores and less need of morphine in various regional blocks.

Keywords: adjuvant; dexmedetomidine; local anesthetics; regional block.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / pharmacology
  • Anesthesia, Conduction*
  • Anesthetics, Local
  • Brachial Plexus Block*
  • Dexmedetomidine*

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Anesthetics, Local
  • Dexmedetomidine